Pages that link to "Q38519160"

The following pages link to Identification of genes whose expression is associated with cisplatin resistance in human ovarian carcinoma cells (Q38519160):

Displaying 23 items.

• Regulation of the Epithelial-Mesenchymal Transition by Claudin-3 and Claudin-4 (Q28534173) (← links)
• A biological question and a balanced (orthogonal) design: the ingredients to efficiently analyze two-color microarrays with Confirmatory Factor Analysis (Q33257297) (← links)
• Carboplatin-induced gene expression changes in vitro are prognostic of survival in epithelial ovarian cancer (Q33387721) (← links)
• Elevated expression of TMEM205, a hypothetical membrane protein, is associated with cisplatin resistance (Q33621526) (← links)
• Challenges associated with the targeted delivery of gelonin to claudin-expressing cancer cells with the use of activatable cell penetrating peptides to enhance potency (Q33814933) (← links)
• Synergy of 1,25-dihydroxyvitamin D3 and carboplatin in growth suppression of SKOV-3 cells (Q33967557) (← links)
• EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer (Q34202046) (← links)
• Meta-analysis of gene expression profiles associated with histological classification and survival in 829 ovarian cancer samples. (Q34209814) (← links)
• HDAC4-regulated STAT1 activation mediates platinum resistance in ovarian cancer. (Q35087685) (← links)
• Tight junction proteins claudin-3 and claudin-4 control tumor growth and metastases (Q36343793) (← links)
• Distinct genetic alterations occur in ovarian tumor cells selected for combined resistance to carboplatin and docetaxel (Q36521792) (← links)
• Synergy between PPARgamma ligands and platinum-based drugs in cancer (Q36930841) (← links)
• Gene-expression profiling in epithelial ovarian cancer (Q37224303) (← links)
• Targeting phosphodiesterase 3B enhances cisplatin sensitivity in human cancer cells (Q37231987) (← links)
• The gene expression profiles of medulloblastoma cell lines resistant to preactivated cyclophosphamide (Q38291073) (← links)
• A systems biology approach to the study of cisplatin drug resistance in ovarian cancers (Q38515955) (← links)
• MDR1 and MDR3 genes and drug resistance to cisplatin of ovarian cancer cells (Q40019065) (← links)
• Gene expression response to cisplatin treatment in drug-sensitive and drug-resistant ovarian cancer cells (Q40214416) (← links)
• Acquired resistance of pancreatic cancer cells to cisplatin is multifactorial with cell context-dependent involvement of resistance genes (Q42351657) (← links)
• MKP-1 suppresses PARP-1 degradation to mediate cisplatin resistance (Q47163224) (← links)
• Key Players of Cisplatin Resistance: Towards a Systems Pharmacology Approach. (Q54259614) (← links)
• Involvement of an Orphan Transporter, SLC22A18, in Cell Growth and Drug Resistance of Human Breast Cancer MCF7 Cells (Q91140980) (← links)
• GADD45B Transcript Is a Prognostic Marker in Papillary Thyroid Carcinoma Patients Treated With Total Thyroidectomy and Radioiodine Therapy (Q95271447) (← links)